The DKK3 complementary peptide (DKK3-CP) can inhibit cellular proliferation, migration, invasion, and in vivo tumor growth of the subcutaneously transplanted tumors with direct injection of DKK3-CP at low doses, and is thought to be a promising new therapeutic reagent. This evidence concerns the gene DKK3 and neoplasm.